MedPath

Nitches, Inc. Enters Bioceutical Market with Launch of InTheZone Labs

• Nitches, Inc. has launched InTheZone Labs, a new vertical focused on bioceutical and nutraceutical products designed to enhance mental focus, vitality, and cognitive development. • The initial product line includes InTheZone Focused, InTheZone Passion, and InTheZone Focused Youth, targeting professionals, adults seeking vitality, and students, respectively. • A Phase One Study, led by medical experts and former NFL athletes, is planned to validate the effectiveness of the InTheZone Labs product line. • Nitches aims to capitalize on the growing nutraceutical and bioceutical market, projected to reach $650 billion by 2027, through its new InTheZone Labs division.

Nitches, Inc. (OTC PINK:NICH) has officially launched InTheZone Labs, a new vertical dedicated to bioceutical and nutraceutical products. This expansion marks Nitches' entry into the health and wellness market, offering products designed to enhance mental focus, vitality, and cognitive development.

InTheZone Labs Product Line

The InTheZone Labs product line features three initial products:
  • InTheZone Focused: Designed for professionals, students, and athletes, this product aims to provide sustained mental performance, enhanced cognitive function, and mental endurance. Key ingredients include Lion's Mane Mushroom, Alpha-GPC, and Phosphatidylserine.
  • InTheZone Passion: This product targets individuals seeking to boost energy levels, enhance overall vitality, and improve emotional well-being. It contains Tribulus Terrestris, Rhodiola Rosea, and a blend of adaptogens.
  • InTheZone Focused Youth: Aimed at younger individuals, this product supports cognitive development, focus, and mental clarity, featuring Creatine Monohydrate, Omega-3 Fatty Acids, and a proprietary blend.

Clinical Validation and Scientific Integrity

To validate the effectiveness of the InTheZone Labs product line, Nitches is initiating a Phase One Study. This study will be conducted under the guidance of a medical doctor, a Doctor of Chiropractic with sports medicine experience, and former NFL athletes and veterans. The goal is to gather data on the products' ability to improve cognitive function, reduce stress, and enhance overall well-being, particularly in individuals with a history of head trauma or high stress levels.

Market Opportunity and Expansion

The global nutraceutical and bioceutical market is projected to exceed $650 billion by 2027. Nitches intends to capitalize on this growth by offering premium, American-made products through InTheZone Labs. The company is also actively building a distribution and affiliate network to expand the reach of its products.

Manufacturing Standards

Nitches' manufacturing partner is certified with Good Manufacturing Practices (GMP), FDA-audited facility standards, NSF, and ISO-90001, ensuring product safety, quality, and efficacy. All products are manufactured in the USA.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

Reference News

[1]
Nitches, Inc. Launches New Vertical With American-Made Bioceutical Company, Introducing ...
stocktitan.net · Oct 9, 2024

Nitches, Inc. launches InTheZone Labs, partnering with an American bioceutical and nutraceutical manufacturer to introdu...

© Copyright 2025. All Rights Reserved by MedPath